Product Overview
Bonetta Deep is a cross-linked, non-animal-origin hyaluronic acid filler gel containing lidocaine hydrochloride 0.3% (w/v). The brand identifies ExocoBio as its manufacturer and South Korea as its country of origin. The photographed Bonetta Filler-Deep presentation contains two 1.1 mL syringes per box. Deep is described by the brand as having balanced viscoelasticity; the related Bonetta Fine and Bonetta Volume lines have their own qualitative formulation descriptions.
Key Features
- Declared formulation: Cross-linked, non-animal-origin hyaluronic acid viscoelastic gel.
- Lidocaine declaration: Lidocaine hydrochloride 0.3% (w/v).
- Packaged presentation: Two syringes per box, each labeled 1.1 mL.
- Deep line characteristic: Brand-described balanced viscoelasticity.
Composition & Specifications
| Specification | Declared information |
|---|---|
| Package name | Bonetta Filler-Deep |
| Product category | Hyaluronic acid face filler |
| Principal material | Cross-linked, non-animal-origin hyaluronic acid |
| Form | Viscoelastic gel |
| Lidocaine content | Lidocaine hydrochloride 0.3% (w/v) |
| Manufacturer | ExocoBio |
| Country of origin | South Korea |
| Volume per syringe | 1.1 mL |
| Package configuration | 2 syringes per box |
Bonetta Line Comparison
The three labeled presentations share the declared hyaluronic acid formulation, lidocaine hydrochloride strength and package configuration shown above. The brand distinguishes the lines using the following qualitative descriptions.
| Catalog line | Brand-described characteristic | Volume per syringe | Package |
|---|---|---|---|
| Bonetta Deep | Balanced viscoelasticity | 1.1 mL | 2 syringes per box |
| Bonetta Fine | Soft texture | 1.1 mL | 2 syringes per box |
| Bonetta Volume | High viscosity and high elasticity | 1.1 mL | 2 syringes per box |
These descriptions are qualitative and do not establish numerical viscosity, elastic-modulus, particle-size or molecular-weight differences.
Product Label & Regulatory Notes
The specifications describe the photographed 1.1 mL syringe presentations. Exact-variant registration numbers and current authorization in the intended market have not been verified.
